Sharon Bio-Medicine Ltd

NSE : SHARONBIO28 Mar 2019

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd

Pharmaceuticals

NSE : SHARONBIO28 Mar 2019

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
14-Jan-2014	S	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 14, 2014, has resolved the following, subject to the approval of the Members: The sub-division of Equity Shares of face value of Rs. 10/- each to Rs. 2/- each. Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors at its meeting held on February 08, 2014 have fixed February 21, 2014 as the Record Date to decide the eligible shareholders of the Company for the following purposes: 1. Splitting / Sub-Division of each Equity Share of Face Value of Rs. 10/- each into Five Equity Shares of Face Value of Rs. 2/- each. (As Per BSE Announcement Dated on 11.02.2014) SUB: Sub Division and Bonus issue of equity shares of Sharon Bio Medicine Ltd. (Scrip Code 532908) Trading Members of the Exchange are hereby informed that, Sharon Bio Medicine Ltd. has fixed the Record Date for the purpose of sub division and bonus issue. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME CODE Sharon Bio Medicine Ltd. (532908) RECORD DATE 21/02/2014 PURPOSE Sub Division of existing equity shares from every 1 (ONE) equity share of Rs. 10/- (TEN) each into 5 (FIVE) equity shares of Rs. 2/- (TWO) each. SUB-DIVIDED PAID-UP VALUE Rs.2/- SUB-DIVIDED PAID-UP VALUE & EX-BONUS W.E.F. 20/02/2014 DR-227/2013- 2014 Note :- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 20/02/2014. ii. ISIN No. INE028B01011 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 20/02/2014. iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 11.02.2014)	21-Feb-2014
21-Nov-2014	D	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 21, 2014, has resolved and recommended dividend @18% which amounts to Rs. 0.36/- per equity share of Rs. 2 each for the Financial Year ended June 30, 2014.	11-Dec-2014
14-Nov-2013	D	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 14, 2013, inter alia, has recommended dividend of Rs. 1.50/- per share on 10556900 equity share of Rs. 10/- each fully paid up for the year ended 2012-13, subject to approval of the members at the ensuing Annual General Meeting.	03-Dec-2013
23-Oct-2012	D	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 22, 2012, inter alia, had resolved and recommended dividend @ Rs. 1.80 per share subject to approval of shareholders at the Annual General Meeting.	03-Jan-2013
21-Oct-2011	D	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 24, 2011, inter alia, has recommended Dividend of Rs. 1.80/- per share on 10556900 equity shares of Rs. 10/- each fully paid up for the year ended June 30, 2011, subject to approval of the members at the ensuing Annual General Meeting.	08-Dec-2011
04-Dec-2010	D	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 04, 2010, inter alia, recommend dividend of Rs.1.50 (i.e 15%) Per Share on 10556900 equity shares of Rs. 10/- each fully paid up, subject to approval of the members at the ensuing Annual General Meeting.	23-Dec-2010
02-Dec-2009	D	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 02, 2009, inter alia, has recommended dividend of @ 12% on 10556900 equity shares of Rs. 10/- each fully paid up for the year ended 2008-2009, subject to approval of the members at the ensuing Annual General Meeting (AGM).	22-Dec-2009
02-Dec-2008	D	Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 02, 2008, inter alia, have recommended dividend of @ 12% on 10556900 equity shares of Rs 10/- each fully paid up for the year ended 2007-2008 subject to approval of the members at the ensuing Annual General Meeting.	19-Dec-2008
25-Jul-2007	D	Sharon Bio Medicine Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 25, 2007, inter alia, has recommended Dividend @ 15% on the equity capital of the Company subject to approval by shareholders.	26-Dec-2007
11-Feb-2014	B	SUB: Bonus issue of equity shares of Sharon Bio Medicine Ltd. (Scrip Code 532908) Trading Members of the Exchange are hereby informed that, Sharon Bio Medicine Ltd. has fixed the Record Date for the purpose of sub division and bonus issue. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME CODE Sharon Bio Medicine Ltd. (532908) RECORD DATE 21/02/2014 PURPOSE Issue of 1 (ONE) bonus equity share of Rs. 2/- (TWO) each for every 1 (ONE) equity share of Rs. 2/- (TWO) held. EX-BONUS W.E.F. 20/02/2014 DR-227/2013- 2014 Note :- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 20/02/2014. ii. ISIN No. INE028B01011 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 20/02/2014. iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.	21-Feb-2014	1:1
10-Apr-2024	BC	We wish to inform that Sharon Bio-Medicine Limited (Material Subsidiary of the Company) has entered into an agreement on April 10, 2024 for purchasing of land admeasuring 4410 sq.mtr.	10-Apr-2024
13-Feb-2024	BC	Trading Members of the Exchange are hereby informed that pursuant to order by the Hon'ble National Company Law Tribunal, Mumbai Bench, dated May 17, 2023, Sharon Bio-Medicine Limited. ('the Company')	20-Feb-2024
07-Jun-2023	BC	Resolution Plan-Extinguishment and Delisting Pursuant to the provisions of Regulation 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and Para 7E of the Order dated Ma	09-Jun-2023
23-May-2023	BC	SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI	30-May-2023
02-Feb-2023	BC	SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Un-Audited Financial Results for The	10-Feb-2023

Announcement Date21-Nov-2014

Ex Dividend Date11-Dec-2014

Dividend(%)18

Announcement Date14-Nov-2013

Ex Dividend Date03-Dec-2013

Dividend(%)15

Announcement Date23-Oct-2012

Ex Dividend Date03-Jan-2013

Dividend(%)18

Announcement Date21-Oct-2011

Ex Dividend Date08-Dec-2011

Dividend(%)18

Announcement Date04-Dec-2010

Ex Dividend Date23-Dec-2010

Dividend(%)15

Announcement Date02-Dec-2009

Ex Dividend Date22-Dec-2009

Dividend(%)12

Announcement Date02-Dec-2008

Ex Dividend Date19-Dec-2008

Dividend(%)12

Announcement Date25-Jul-2007

Ex Dividend Date26-Dec-2007

Dividend(%)15

No Rights has been declared by SHARONBIO

Book Closure

Record Date	Split Date	Purpose
10-Apr-2024	-	We wish to inform that Sharon Bio-Medicine Limited (Material Subsidiary of the Company) has entered into an agreement on April 10, 2024 for purchasing of land admeasuring 4410 sq.mtr.
20-Feb-2024	-	Trading Members of the Exchange are hereby informed that pursuant to order by the Hon'ble National Company Law Tribunal, Mumbai Bench, dated May 17, 2023, Sharon Bio-Medicine Limited. ('the Company')
09-Jun-2023	-	Resolution Plan-Extinguishment and Delisting Pursuant to the provisions of Regulation 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and Para 7E of the Order dated Ma
30-May-2023	-	SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI
10-Feb-2023	-	SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Un-Audited Financial Results for The

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sharon Bio-Medicine Ltd ₹3.30(0.00/0.00%)	3.30	+0.00	39.25	-40.00	2.01	-0.07
Lupin Ltd ₹2,201.15(+15.80/0.72%)	2,201.15	+15.80	100,478.32	38.30	33.50	4.57
Ipca Laboratories Ltd ₹1,507.25(-7.65/-0.50%)	1,507.25	-7.65	38,239.57	26.33	54.77	5.67
J B Chemicals & Pharmaceuticals Ltd ₹1,671.25(-45.20/-2.63%)	1,671.25	-45.20	26,005.71	-0.51	41.43	8.25
IOL Chemicals & Pharmaceuticals Ltd ₹384.20(+0.60/0.16%)	384.20	+0.60	2,255.47	-13.44	22.50	1.36
Sanofi India Ltd ₹5,471.70(-47.75/-0.87%)	5,471.70	-47.75	12,601.33	-37.71	29.89	18.41

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012
Cash and Cash Equivalents at Beginning of the year	16.01	12.27	6.27	6.28	3.84
Net Cash from Operating Activities	-28.21	-81.91	-69.47	-70.23	-52.98
Net Cash Used In Investing Activities	0.14	-10.06	-27.38	-64.28	-61.24
Net Cash Used In Financing Activities	22.22	95.70	102.85	134.50	116.66
Net Inc./Dec In Cash And Cash Equivalents	-5.85	3.73	6.00	-0.01	2.44
Cash And Cash Equivalents At End Of The Year	10.16	16.01	12.27	6.27	6.28

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.19%

Public Shareholding

99.81%

**Promoter pledged shareholding 0.00%

About Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 38.18 crores. It has reported a sales of Rs. 43 crores and a net profit of Rs. 1.81 crores for the quarter ended December 2018. The company management includes Savita Gowda, Savita Gowda,Lalit Misra,Nivedita Patil,Harish Palecanda (Sharon Bio-Medicine Ltd) among others.

Chairman

Savita Gowda

Registered office

W-34 34/1 MIDC,Taloja,Raigad,Maharashtra,410208

FAX :

Background

Incorporation Year1989

Face Value₹2

Market Lot1